A new blood sample analysis has revealed molecular differences that help identify preterm birth risk during the first trimester. Indeed, Emory University researchers suggest maternal blood biomarkers can predict delivery timing. Consequently, clinicians may soon predict early-term and preterm deliveries to improve infant health.

Assessing Preterm Birth Risk through Metabolomics

To identify these predictors, researchers conducted a metabolome-wide association study. Consequently, they analyzed serum samples from over 500 pregnant women within the Atlanta African American Maternal-Child Cohort. The team collected maternal blood during early pregnancy (weeks 8-14) and late pregnancy (weeks 24-30). Thus, they successfully mapped the relationship between small-molecule metabolites and birth outcomes.

Spontaneous vs. Medically Indicated Births

Interestingly, the study revealed distinct metabolic profiles for different delivery circumstances. For instance, in cases of spontaneous early births, mothers' blood showed altered levels of specific amino acids. These amino acids, such as valine, leucine, and tyrosine, play a key role in fetal growth and placenta development. Additionally, pathways involving arginine, proline, aspartate, and glutamate showed significant perturbations. These pathways directly regulate oxidative stress and the body's acute inflammatory response.

On the other hand, medically indicated early deliveries showed an entirely different metabolic footprint. Specifically, these blood samples exhibited changes in acylcarnitine and the steroid hormone aldosterone. These specific biomolecules reflect how the maternal body manages cardiovascular stress and fat metabolism. Therefore, researchers can now distinguish between spontaneous and medically indicated preterm risks through targeted blood analysis.

Clinical Relevance and Future Implications

Preterm births (before week 37) and early-term births (weeks 37-38) pose severe health risks for infants. Crucial organs like the brain and lungs develop rapidly during the final weeks of pregnancy. Consequently, early birth can cause breathing problems and hearing loss. Fortunately, early identification of metabolic disruptions allows clinicians to intervene sooner. Consequently, this study could lead to routine first-trimester screenings, ultimately improving survival rates and developmental outcomes for vulnerable newborns.

Frequently Asked Questions

Q1: What are the main molecular differences between spontaneous and medically indicated early births?

Spontaneous early births are primarily linked to disruptions in maternal amino acids like valine, leucine, and tyrosine, which affect fetal growth and inflammatory responses. In contrast, medically indicated early births are associated with markers like acylcarnitine and aldosterone, which indicate metabolic stress and cardiovascular burden.

Q2: When can these maternal blood biomarkers first be detected?

According to the Emory University study, distinct molecular signs of preterm and early-term delivery risks can appear in the mother's blood as early as the first trimester, between weeks 8 and 14 of pregnancy.

Q3: Why are early-term and preterm births clinically concerning?

Babies born before week 39 may have underdeveloped organs, particularly the brain and lungs. Consequently, early deliveries can lead to lasting health issues, including breathing problems, developmental delays, and hearing loss.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.

References

1. Analysis of blood samples reveal molecular differences between early, pre-termdeliveries - ETHealthworld


2. Taibl KR, Dunlop AL, Barr DB, et al. Newborn metabolomic signatures of maternal per- and polyfluoroalkyl substance exposure and reduced length of gestation. Nat Commun. 2023;14(1):3120.


3. Tan Y, Li Z, Dunlop AL, et al. Associations between prenatal exposure to ambient air pollutants and preterm birth in the Atlanta African American maternal-child cohort. Environ Health. 2026;25:12.